Big Pharma CEO Arrested For Bribing Doctors To Prescribe Deadly Opioid

Friday, October 27, 2017
By Paul Martin

Baxter Dmitry
YourNewsWire.com
October 27, 2017

Big Pharma billionaire and CEO John Kapoor was arrested by federal agents for allegedly bribing doctors into prescribing a highly addictive opioid pain medication and destroying untold thousands of lives, the Department of Justice said.

John Kapoor, the founder and CEO of Insys Therapeutics, Inc., is accused of “leading a nationwide conspiracy to profit by using bribes and fraud to cause the illegal distribution of Subsys, a powerful Fentanyl spray intended for cancer patients experiencing breakthrough pain,” the DOJ said.

The arrest came on the same day President Trump declared a national emergency to fight opioid addiction in the United States. “We owe it to our children and to our country to do everything in our power to address this national shame and human tragedy,” Trump said.

Big Pharma boss John Kapoor faces several felony charges, including RICO conspiracy, conspiracy to commit mail and wire fraud and conspiracy to violate the Anti-Kickback Law, and is facing decades in prison and millions of dollars in fines, according to UPI.

“In the midst of a nationwide opioid epidemic that has reached crisis proportions, Mr. Kapoor and his company stand accused of bribing doctors to overprescribe a potent opioid and committing fraud on insurance companies solely for profit,” said Acting United States Attorney William D. Weinreb.

He added: “We must hold the industry and its leadership accountable — just as we would the cartels or a street-level drug dealer.“

The arrest of the Big Pharma billionaire has added weight to claims that doctors are operating irresponsibly, endangering the health and lives of their patients, as they seek to make as much money as possible from the Big Pharma companies.

The Rest…HERE

Leave a Reply

Join the revolution in 2018. Revolution Radio is 100% volunteer ran. Any contributions are greatly appreciated. God bless!

Follow us on Twitter